- 询价
- Signalway Antibody
- 33935
- 2025年09月22日
- WB IHC IF
- Rabbit
- Human
企业认证
相关产品推荐更多 >
![mStrawberry Mouse Polyclonal Antibody[38082]](https://img1.dxycdn.com/p/s14/2025/0922/359/6146153295428599691.jpg!wh200)
![PUF60 Antibody[43085]](https://img1.dxycdn.com/p/s14/2025/0922/568/0046652811090600791.jpg!wh200)
![LGR4 Conjugated Antibody[C37703]](https://img1.dxycdn.com/p/s14/2025/0923/278/4431488150116040791.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Synthesized peptide derived from C-terminal of human TM16G.
- 形态：
liquid
- 保存条件：
Store at -20˚C
- 克隆性：
Polyclonal
- 适应物种：
Human
- 保质期：
12 months
- 抗原来源：
Rabbit
- 供应商：
南京赛戈巍生物科技有限公司
- 宿主：
Rabbit
- 应用范围：
WB IHC IF
- 靶点：
Uniprot：Q6IWH7
- 抗体英文名：
TM16G Antibody
- 规格：
50ul/100ul
配方:Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
应用详情:Western blotting: 1:500~1:3000
Immunohistochemistry: 1:50~1:100
Immunofluorescence: 1:100~1:500
图片:
Western blot analysis of extracts from LOVO cells, using TM16G antiobdy #33935.
,
Immunohistochemistry analysis of paraffin-embedded human prostate carcinoma tissue, using TM16G antibody #33935.
,
Immunofluorescence analysis of HepG2 cells, using TM16G antibody #33935.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验ANTIBODY BINDING TO PROTEIN A AND PROTEIN G
Protein A, derived from the cell wall of Staphylococcus aureus , and protein G, derived from the cell wall of certain strains of b -hemolytic Streptococcci , binds the Fc region
Antibody Purification: Affinity Chromatography Protein A and Protein G Sepharose
G coupled to agarose. In the Subheading 3 there are also protocols for affinity purification using a specific ligand coupled to commercial matrices like CNBr- Sepharose 4-B and Affigel.
Analysis and Purification of Antibody Fragments Using Protein A, Protein G, and Protein L
Today, monoclonal antibodies (mAbs) form the largest category of biopharmaceuticals in clinical trials and their number is expanding rapidly (DataMonitor 2007). The antibodies or functional antibody fragments are being produced in artificial
技术资料暂无技术资料 索取技术资料
